Aripiprazole is associated with early onset of Tardive Dyskinesia like presentation in a patient with ABI and psychosis.
OBJECTIVE
This report describes the early onset Tardive Dyskinesia like presentation during treatment with Aripiprazole.


METHODS
The patient, who had a history of acquired brain injury, was receiving treatment for his psychotic illness characterized by persecutory delusions, second person auditory hallucinations, self-neglect and challenging behaviours. Tardive Dyskinesia is not a well reported side-effect of Aripiprazole.


CONCLUSIONS
This report demonstrates onset of this side-effect upon commencement of Aripiprazole and cessation of this side-effect upon termination of this medication. This case report highlights the need for careful monitoring of neurological side-effects in patients with acquired brain injury requiring treatment with anti-psychotic medication.
Zaidi
Syed Habib Haider
SH
Kemsley, National Centre for Brain Injury Rehabilitation, St Andrew's HealthCare, Northampton, UK. shaider@standrew.co.uk
Faruqui
Rafey A
RA
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D000068180:Aripiprazole; D001930:Brain Injuries / Q000523:psychology*; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D006801:Humans; D008297:Male; D010879:Piperazines / Q000009:adverse effects*; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy*; D015363:Quinolones / Q000009:adverse effects*; D016896:Treatment Outcome; D028761:Withholding Treatment
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole